These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33999032)

  • 1. Medium-Throughput Drug- and Radiotherapy Screening Assay using Patient-Derived Organoids.
    Putker M; Millen R; Overmeer R; Driehuis E; Zandvliet MMJM; Clevers H; Boj SF; Li QX
    J Vis Exp; 2021 Apr; (170):. PubMed ID: 33999032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
    Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
    Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Organoid-Based Preclinical Model of Human Gastric Cancer.
    Steele NG; Chakrabarti J; Wang J; Biesiada J; Holokai L; Chang J; Nowacki LM; Hawkins J; Mahe M; Sundaram N; Shroyer N; Medvedovic M; Helmrath M; Ahmad S; Zavros Y
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):161-184. PubMed ID: 30522949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening.
    Verissimo CS; Overmeer RM; Ponsioen B; Drost J; Mertens S; Verlaan-Klink I; Gerwen BV; van der Ven M; Wetering MV; Egan DA; Bernards R; Clevers H; Bos JL; Snippert HJ
    Elife; 2016 Nov; 5():. PubMed ID: 27845624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological Factors as Predictors for Establishment of Patient Derived Head and Neck Squamous Cell Carcinoma Organoids.
    de Kort WWB; Millen R; Driehuis E; Devriese LA; van Es RJJ; Willems SM
    Head Neck Pathol; 2024 Jun; 18(1):59. PubMed ID: 38940869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing Susceptibility of Patient-Derived Organoid Cultures to Therapies: Pharmacotyping.
    Burkhart RA; Baker LA; Tiriac H
    Methods Mol Biol; 2018; 1787():253-261. PubMed ID: 29736724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of patient-derived cancer organoids for drug-screening applications.
    Driehuis E; Kretzschmar K; Clevers H
    Nat Protoc; 2020 Oct; 15(10):3380-3409. PubMed ID: 32929210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-derived head and neck cancer organoids allow treatment stratification and serve as a tool for biomarker validation and identification.
    Millen R; De Kort WWB; Koomen M; van Son GJF; Gobits R; Penning de Vries B; Begthel H; Zandvliet M; Doornaert P; Raaijmakers CPJ; Geurts MH; Elias SG; van Es RJJ; de Bree R; Devriese LA; Willems SM; Kranenburg O; Driehuis E; Clevers H
    Med; 2023 May; 4(5):290-310.e12. PubMed ID: 37178682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of Patient-Derived Organoids and Drug Screening for Biliary Tract Carcinoma.
    Saito Y; Muramatsu T; Kanai Y; Ojima H; Sukeda A; Hiraoka N; Arai E; Sugiyama Y; Matsuzaki J; Uchida R; Yoshikawa N; Furukawa R; Saito H
    Cell Rep; 2019 Apr; 27(4):1265-1276.e4. PubMed ID: 31018139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Patient-Derived Gastric Cancer Organoids from Endoscopic Biopsies and Surgical Tissues.
    Gao M; Lin M; Rao M; Thompson H; Hirai K; Choi M; Georgakis GV; Sasson AR; Bucobo JC; Tzimas D; D'Souza LS; Buscaglia JM; Davis J; Shroyer KR; Li J; Powers S; Kim J
    Ann Surg Oncol; 2018 Sep; 25(9):2767-2775. PubMed ID: 30003451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical investigation of patient-derived cervical cancer organoids for precision medicine.
    Seol HS; Oh JH; Choi E; Kim S; Kim H; Nam EJ
    J Gynecol Oncol; 2023 May; 34(3):e35. PubMed ID: 36659831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The organoid as reliable cancer modeling in personalized medicine, does applicable in precision medicine of head and neck squamous cell carcinoma?
    Farshbaf A; Lotfi M; Zare R; Mohtasham N
    Pharmacogenomics J; 2023 May; 23(2-3):37-44. PubMed ID: 36347937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and Characterization of Patient-Derived Head and Neck, Oral, and Esophageal Cancer Organoids.
    Karakasheva TA; Kijima T; Shimonosono M; Maekawa H; Sahu V; Gabre JT; Cruz-Acuña R; Giroux V; Sangwan V; Whelan KA; Natsugoe S; Yoon AJ; Philipone E; Klein-Szanto AJ; Ginsberg GG; Falk GW; Abrams JA; Que J; Basu D; Ferri L; Diehl JA; Bass AJ; Wang TC; Rustgi AK; Nakagawa H
    Curr Protoc Stem Cell Biol; 2020 Jun; 53(1):e109. PubMed ID: 32294323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug screening by uniform patient derived colorectal cancer hydro-organoids.
    Jung YH; Choi DH; Park K; Lee SB; Kim J; Kim H; Jeong HW; Yang JH; Kim JA; Chung S; Min BS
    Biomaterials; 2021 Sep; 276():121004. PubMed ID: 34273688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-derived cancer organoids for drug screening: Basic technology and clinical application.
    Ren X; Chen W; Yang Q; Li X; Xu L
    J Gastroenterol Hepatol; 2022 Aug; 37(8):1446-1454. PubMed ID: 35771719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Imaging of Head and Neck Cancer Organoids.
    Shah AT; Heaster TM; Skala MC
    PLoS One; 2017; 12(1):e0170415. PubMed ID: 28099487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective derivation of a living organoid biobank of colorectal cancer patients.
    van de Wetering M; Francies HE; Francis JM; Bounova G; Iorio F; Pronk A; van Houdt W; van Gorp J; Taylor-Weiner A; Kester L; McLaren-Douglas A; Blokker J; Jaksani S; Bartfeld S; Volckman R; van Sluis P; Li VS; Seepo S; Sekhar Pedamallu C; Cibulskis K; Carter SL; McKenna A; Lawrence MS; Lichtenstein L; Stewart C; Koster J; Versteeg R; van Oudenaarden A; Saez-Rodriguez J; Vries RG; Getz G; Wessels L; Stratton MR; McDermott U; Meyerson M; Garnett MJ; Clevers H
    Cell; 2015 May; 161(4):933-45. PubMed ID: 25957691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic characteristics and drug screening among organoids derived from non-small cell lung cancer patients.
    Chen JH; Chu XP; Zhang JT; Nie Q; Tang WF; Su J; Yan HH; Zheng HP; Chen ZX; Chen X; Song MM; Yi X; Li PS; Guan YF; Li G; Deng CX; Rosell R; Wu YL; Zhong WZ
    Thorac Cancer; 2020 Aug; 11(8):2279-2290. PubMed ID: 32633046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy.
    Narasimhan V; Wright JA; Churchill M; Wang T; Rosati R; Lannagan TRM; Vrbanac L; Richardson AB; Kobayashi H; Price T; Tye GXY; Marker J; Hewett PJ; Flood MP; Pereira S; Whitney GA; Michael M; Tie J; Mukherjee S; Grandori C; Heriot AG; Worthley DL; Ramsay RG; Woods SL
    Clin Cancer Res; 2020 Jul; 26(14):3662-3670. PubMed ID: 32376656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.